SK279938B6 - Farmaceuticky účinné adičné soli s kyselinami odvo - Google Patents

Farmaceuticky účinné adičné soli s kyselinami odvo Download PDF

Info

Publication number
SK279938B6
SK279938B6 SK3152-92A SK315292A SK279938B6 SK 279938 B6 SK279938 B6 SK 279938B6 SK 315292 A SK315292 A SK 315292A SK 279938 B6 SK279938 B6 SK 279938B6
Authority
SK
Slovakia
Prior art keywords
acid
formula
acids
addition salts
derived
Prior art date
Application number
SK3152-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK315292A3 (en
Inventor
Jaroslav Stanek
J�rg FREI
Giorgio Caravatti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK315292A3 publication Critical patent/SK315292A3/sk
Publication of SK279938B6 publication Critical patent/SK279938B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Detergent Compositions (AREA)
  • Cereal-Derived Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
SK3152-92A 1991-10-16 1992-10-16 Farmaceuticky účinné adičné soli s kyselinami odvo SK279938B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH304191 1991-10-16

Publications (2)

Publication Number Publication Date
SK315292A3 SK315292A3 (en) 1995-04-12
SK279938B6 true SK279938B6 (sk) 1999-06-11

Family

ID=4247296

Family Applications (1)

Application Number Title Priority Date Filing Date
SK3152-92A SK279938B6 (sk) 1991-10-16 1992-10-16 Farmaceuticky účinné adičné soli s kyselinami odvo

Country Status (24)

Country Link
EP (1) EP0538193B1 (cs)
JP (1) JP2788579B2 (cs)
KR (1) KR100265307B1 (cs)
AT (1) ATE145896T1 (cs)
AU (1) AU658931B2 (cs)
CA (1) CA2080545C (cs)
CY (1) CY2127B1 (cs)
CZ (1) CZ279601B6 (cs)
DE (1) DE59207617D1 (cs)
DK (1) DK0538193T3 (cs)
ES (1) ES2095444T3 (cs)
FI (1) FI112212B (cs)
GR (1) GR3021903T3 (cs)
HK (1) HK1005023A1 (cs)
HU (1) HU226954B1 (cs)
IL (1) IL103448A (cs)
MX (1) MX9205934A (cs)
NO (1) NO178108C (cs)
NZ (1) NZ244725A (cs)
RU (1) RU2081108C1 (cs)
SA (1) SA93130417B1 (cs)
SG (1) SG43185A1 (cs)
SK (1) SK279938B6 (cs)
ZA (1) ZA927957B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103166B1 (es) * 1992-08-26 1998-04-01 Ciba Geigy Ag Procedimiento para la obtencion de amidinohidrazonas biciclicas.
CN101220366B (zh) * 1994-12-09 2011-10-05 味之素株式会社 新的赖氨酸脱羧酶基因以及生产l-赖氨酸的方法
WO1996022979A1 (en) * 1995-01-26 1996-08-01 Novartis Ag Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
EP1483231A1 (de) * 2002-03-04 2004-12-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue salmeterol-zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1884515A1 (en) 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645799B2 (en) * 1990-05-07 1994-01-27 Novartis Ag Hydrazones

Also Published As

Publication number Publication date
HU9203234D0 (en) 1992-12-28
KR100265307B1 (ko) 2000-09-15
SA93130417B1 (ar) 2005-11-12
AU2704092A (en) 1993-04-22
KR930007896A (ko) 1993-05-20
MX9205934A (es) 1993-04-01
IL103448A (en) 1998-01-04
EP0538193B1 (de) 1996-12-04
FI924650A0 (fi) 1992-10-14
SK315292A3 (en) 1995-04-12
CA2080545C (en) 2005-11-29
JPH05239011A (ja) 1993-09-17
HUT63149A (en) 1993-07-28
CZ279601B6 (cs) 1995-05-17
DE59207617D1 (de) 1997-01-16
EP0538193A2 (de) 1993-04-21
NO178108B (no) 1995-10-16
DK0538193T3 (da) 1996-12-23
FI112212B (fi) 2003-11-14
NO178108C (no) 1996-01-24
FI924650A7 (fi) 1993-04-17
CA2080545A1 (en) 1993-04-17
EP0538193A3 (en) 1993-06-16
NO924001L (no) 1993-04-19
ES2095444T3 (es) 1997-02-16
GR3021903T3 (en) 1997-03-31
IL103448A0 (en) 1993-03-15
RU2081108C1 (ru) 1997-06-10
CZ315292A3 (en) 1993-05-12
JP2788579B2 (ja) 1998-08-20
SG43185A1 (en) 1997-10-17
ATE145896T1 (de) 1996-12-15
HK1005023A1 (en) 1998-12-18
AU658931B2 (en) 1995-05-04
ZA927957B (en) 1993-04-26
NO924001D0 (no) 1992-10-15
NZ244725A (en) 1995-05-26
HU226954B1 (en) 2010-03-29
CY2127B1 (en) 2002-06-21

Similar Documents

Publication Publication Date Title
JP2664241B2 (ja) アリールヒドラゾン
US5064832A (en) Biaryl compounds
PL174279B1 (pl) Pochodne kwasu hydroksamowego
EP0302603A1 (en) Dopamine-beta-hydroxylase inhibitors
JPH06234727A (ja) 置換されたベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
SK279938B6 (sk) Farmaceuticky účinné adičné soli s kyselinami odvo
US4472422A (en) Antihypertensive 4,5-diaryl-α-polyfluoro-alkyl-1H-imidazole-2-methanamines
EP0456133B1 (de) Hydrazone
HK1000919B (en) Hydrazones
CZ419291A3 (en) Benzene derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
US5238941A (en) Arylhydrazones and pharmaceutical compositions thereof
CA1120041A (en) .alpha.-HALOMETHYL DERIVATIVES OF AMINO ACIDS
WO1989006127A1 (en) 2-AMINOALKYLTHIOIMIDAZOLES AS DOPAMINE-beta-HYDROXYLASE INHIBITORS
EP1140803B1 (en) ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
AU648377B2 (en) Bipyridyls
EP1047668B1 (en) Triazepinones, process for their preparation and their therapeutic application
JPS6059230B2 (ja) 不整脈抑制性フエネチルピペリジン化合物
ZA200109624B (en) Salts of cis-c4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20101016